Compare · CI vs GRAL
CI vs GRAL
Side-by-side comparison of The Cigna Group (CI) and GRAIL Inc. (GRAL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CI and GRAL operate in Medical Specialities (Health Care), so they compete in similar markets.
- CI is the larger of the two at $73.81B, about 20.0x GRAL ($3.69B).
- Both names hit the wire about 7 times in the past 4 weeks.
- CI has more recent analyst coverage (25 ratings vs 12 for GRAL).
- Company
- The Cigna Group
- GRAIL Inc.
- Price
- -
- -
- Market cap
- $73.81B
- $3.69B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 7
- 7
- Recent ratings
- 25
- 12
The Cigna Group
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Latest CI
- SEC Form 4 filed by Officer Holgerson Bryan
- Officer Jones Nicole S sold $748,516 worth of shares (2,677 units at $279.61) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 25,880 units (SEC Form 4)
- SEC Form 144 filed by The Cigna Group
- Officer Jones Nicole S exercised 15,346 shares at a strike of $192.02 and sold $5,369,584 worth of shares (19,436 units at $276.27) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 28,557 units (SEC Form 4)
- SEC Form 144 filed by The Cigna Group
- The Cigna Group downgraded by Jefferies with a new price target
- The Cigna Group downgraded by Raymond James with a new price target
- SEC Form 10-Q filed by The Cigna Group
- The Cigna Group filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Cigna Group Reports Strong Second Quarter 2026 Results, Raises 2026 Outlook
Latest GRAL
- Amendment: SEC Form SCHEDULE 13G/A filed by GRAIL Inc.
- GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
- SEC Form SCHEDULE 13G filed by GRAIL Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by GRAIL Inc.
- SEC Form 10-Q filed by GRAIL Inc.
- GRAIL Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GRAIL Reports Second Quarter 2026 Financial Results
- GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference
- GRAIL to Announce Second Quarter 2026 Financial Results
- Director Chase William J was granted 276 shares, increasing direct ownership by 0.65% to 42,978 units (SEC Form 4)